Although detailed mechanisms underlying these effects are yet to be elucidated, these findings imply that aberrant expression of GAG synthases, such as CHSY1, could provide a molecular basis for targeting PDGFRA pathway in glioma. The gene discussed is PDGFRA; the disease is central nervous system cancer.